Prognostic factors for adalimumab used in steroid-dependent Crohn's disease

[Igor_Passau]

This study shows that adalimumab is a powerful and safe weapon for steroid discontinuation in patients with steroid-dependent Crohn's disease."

"Higher induction regimen dosage is the better therapeutic choice for achieving clinical remission with low risk of clinical relapse."

http://www.gastrohep.com/news/news.asp?id=108784